PortalPublikationenBMT CTN Myeloma Intergroup Workshop on Minimal Residual Dise...

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

Standard

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee. / Holstein, Sarah A; Avet-Loiseau, Hervé; Hahn, Theresa; Ho, Christine M; Lohr, Jens G; Munshi, Nikhil C; Paiva, Bruno; Pasquini, Marcelo C; Tario, Joseph D; Usmani, Saad Z; Wallace, Paul K; Weisel, Katja; McCarthy, Philip L.

in: BIOL BLOOD MARROW TR, Jahrgang 24, Nr. 4, 04.2018, S. 641-648.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Holstein, SA, Avet-Loiseau, H, Hahn, T, Ho, CM, Lohr, JG, Munshi, NC, Paiva, B, Pasquini, MC, Tario, JD, Usmani, SZ, Wallace, PK, Weisel, K & McCarthy, PL 2018, 'BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee', BIOL BLOOD MARROW TR, Jg. 24, Nr. 4, S. 641-648. https://doi.org/10.1016/j.bbmt.2017.12.774

APA

Holstein, S. A., Avet-Loiseau, H., Hahn, T., Ho, C. M., Lohr, J. G., Munshi, N. C., Paiva, B., Pasquini, M. C., Tario, J. D., Usmani, S. Z., Wallace, P. K., Weisel, K., & McCarthy, P. L. (2018). BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee. BIOL BLOOD MARROW TR, 24(4), 641-648. https://doi.org/10.1016/j.bbmt.2017.12.774

Vancouver

Holstein SA, Avet-Loiseau H, Hahn T, Ho CM, Lohr JG, Munshi NC et al. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee. BIOL BLOOD MARROW TR. 2018 Apr;24(4):641-648. https://doi.org/10.1016/j.bbmt.2017.12.774

Bibtex

@article{0476e2b1943d4ffa8880659506cd90a7,
title = "BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee",
abstract = "The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design.",
keywords = "Clinical Trials as Topic, Education, Hematology, Humans, Multiple Myeloma, Neoplasm, Residual, Practice Guidelines as Topic, Societies, Medical, United States, Journal Article, Research Support, N.I.H., Extramural, Review",
author = "Holstein, {Sarah A} and Herv{\'e} Avet-Loiseau and Theresa Hahn and Ho, {Christine M} and Lohr, {Jens G} and Munshi, {Nikhil C} and Bruno Paiva and Pasquini, {Marcelo C} and Tario, {Joseph D} and Usmani, {Saad Z} and Wallace, {Paul K} and Katja Weisel and McCarthy, {Philip L}",
note = "Copyright {\textcopyright} 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.",
year = "2018",
month = apr,
doi = "10.1016/j.bbmt.2017.12.774",
language = "English",
volume = "24",
pages = "641--648",
journal = "BIOL BLOOD MARROW TR",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

AU - Holstein, Sarah A

AU - Avet-Loiseau, Hervé

AU - Hahn, Theresa

AU - Ho, Christine M

AU - Lohr, Jens G

AU - Munshi, Nikhil C

AU - Paiva, Bruno

AU - Pasquini, Marcelo C

AU - Tario, Joseph D

AU - Usmani, Saad Z

AU - Wallace, Paul K

AU - Weisel, Katja

AU - McCarthy, Philip L

N1 - Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

PY - 2018/4

Y1 - 2018/4

N2 - The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design.

AB - The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design.

KW - Clinical Trials as Topic

KW - Education

KW - Hematology

KW - Humans

KW - Multiple Myeloma

KW - Neoplasm, Residual

KW - Practice Guidelines as Topic

KW - Societies, Medical

KW - United States

KW - Journal Article

KW - Research Support, N.I.H., Extramural

KW - Review

U2 - 10.1016/j.bbmt.2017.12.774

DO - 10.1016/j.bbmt.2017.12.774

M3 - SCORING: Review article

C2 - 29242112

VL - 24

SP - 641

EP - 648

JO - BIOL BLOOD MARROW TR

JF - BIOL BLOOD MARROW TR

SN - 1083-8791

IS - 4

ER -